DUO dote autoinjectors
Ended Awarded Last action
- Contract number
- 19AQMM25F1560
- Awardee
-
Meridian Medical Technologies, LLC UEI VBM4PLZ9VBC4
- Awarding agency
-
Office of Acquisition Management
Department of State
- Obligated
- $992,655
Award facts
- Opportunity
-
- 19AQMM23R0065 Solicitation number
- Contract value 100% obligated
- $992,655.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Bureau of Medical Services Department of State
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- St. Louis, MO 63146, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $992,655 |
About this award
Meridian Medical Technologies, LLC, a Pfizer subsidiary specializing in medical countermeasures, was awarded a $992,655 delivery order by the Department of State's Bureau of Medical Services on September 30, 2024. This firm-fixed-price order, issued without set-aside designation, is for DuoDote autoinjectors—dual-agent devices containing atropine and pralidoxime chloride for treating nerve agent exposure. The delivery order is performance-based through September 29, 2025, with the place of performance located in St. Louis, Missouri, where Meridian maintains its primary manufacturing operations.
This delivery order is issued under the MANDRAKE 3.0 Indefinite Delivery, Indefinite Quantity contract, a five-year vehicle established by the Department of State with a $100 million ceiling through September 2025. The MANDRAKE 3.0 contract authorizes the supply of autoinjectors and associated training devices to State Department personnel globally. This particular delivery order represents the third issuance under the IDIQ vehicle, following two prior orders valued at $17.9 million and $2.5 million, bringing the total delivery order value under MANDRAKE 3.0 to approximately $21.4 million. Meridian's selection as the sole contractor reflects its established expertise in autoinjector manufacturing and its critical position as a key federal supplier of nerve agent antidote medical countermeasures.
Quick answers
Who was awarded contract 19AQMM25F1560?
19AQMM25F1560 was awarded to Meridian Medical Technologies, LLC by Office of Acquisition Management (Department of State) on September 30, 2024.
How much is contract 19AQMM25F1560 worth?
The government has obligated $992,655 on 19AQMM25F1560.
Which agency awarded contract 19AQMM25F1560?
Office of Acquisition Management (Department of State) awarded 19AQMM25F1560, with funding from Bureau of Medical Services (Department of State).
Is contract 19AQMM25F1560 an order under another contract?
Yes. 19AQMM25F1560 is a delivery order under 19AQMM23D0093, an indefinite delivery contract.
Was contract 19AQMM25F1560 competed?
The extent of competition for 19AQMM25F1560 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award